(PDF) Cyclophilin A, TRIM5, and Resistance to Human

Cyclophilin A, TRIM5, and Resistance to Human Immunodeficiency Virus Type 1 Infection

Journal of Virology - United States

doi 10.1128/jvi.01519-06

Full Text

Abstract

Available in full text

Categories

Date

September 6, 2006

Authors

Publisher

American Society for Microbiology

Related search

Cyclophilin a Renders Human Immunodeficiency Virus Type 1 Sensitive to Old World Monkey but Not Human TRIM5 Antiviral Activity

Journal of Virology

English

Target Cell Cyclophilin a Modulates Human Immunodeficiency Virus Type 1 Infectivity

Journal of Virology

English

Biochemical Characterization of a Recombinant TRIM5 Protein That Restricts Human Immunodeficiency Virus Type 1 Replication

Journal of Virology

English

Differential Restriction of Human Immunodeficiency Virus Type 2 and Simian Immunodeficiency Virus SIVmac by TRIM5 Alleles

Journal of Virology

English

Virus Population Homogenization Following Acute Human Immunodeficiency Virus Type 1 Infection

Journal of Virology

English

Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection Through Virus Binding

Journal of Virology

English

Determinants of Human Immunodeficiency Virus Type 1 Resistance to Membrane-Anchored Gp41-Derived Peptides

Journal of Virology

English

Active-Site Residues of Cyclophilin a Are Crucial for Its Incorporation Into Human Immunodeficiency Virus Type 1 Virions.

Journal of Virology

English

Nef-Mediated Resistance of Human Immunodeficiency Virus Type 1 to Antiviral Cytotoxic T Lymphocytes

Journal of Virology

English